pharma · Asthma · Osteoarthritis · AMRX
Amneal Pharma Europe
Amneal Pharma Europe Ltd
Amneal Pharma Europe clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 400 Crossing Boulevard, Bridgewater, New Jersey 08807, US
- Founded
- 2002
- Employees
- 7,179
- Programs
- 15
- Drugs
- 210
- Patents
- 32
Amneal Pharma Europe projects
11 ClinicalTrials.gov programs sponsored by Amneal Pharma Europe.
Amneal Pharma Europe has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AM-PHN-004
Amneal Pharma Europe Ltd
Uncomplicated Urinary Tract Infections
1 trial -
Asenapine Sublingual Tablets 10 mg
Amneal Pharma Europe Ltd
Schizophrenia
1 trial -
Diclofenac Sodium Topical Gel, 1%
Amneal Pharma Europe Ltd
Osteoarthritis
1 trial -
Estradiol Vaginal Tablets 10 mcg
Amneal Pharma Europe Ltd
Atrophic Vaginitis Due to Menopause
1 trial -
Imatinib Mesylate Tablets, 400 mg
Amneal Pharma Europe Ltd
Chronic Myeloid Leukemia
1 trial -
Mometasone Furoate Nasal Spray, 50 mcg
Amneal Pharma Europe Ltd
Seasonal Allergic Rhinitis
1 trial -
Phenazopyridine Hydrochloride
Amneal Pharma Europe Ltd
Pain
1 trial -
Placebo
Amneal Pharma Europe Ltd
Asthma
1 trial -
Test - Bimatoprost 0.01% Ophthalmic Solution
Amneal Pharma Europe Ltd
Glaucoma, Open-Angle
1 trial -
Test Product
Amneal Pharma Europe Ltd
Asthma
2 trials -
Testosterone Topical Gel, 1.62% Metered Pump
Amneal Pharma Europe Ltd
Primary Hypogonadism
1 trial
Frequently asked questions
How many clinical projects does Amneal Pharma Europe have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.